Enteric fever, primarily caused by Salmonella Typhi and Paratyphi, remains a significant global health challenge, particularly in resource-limited settings. This article presents a comprehensive approach to the effective management of enteric fever, reinforcing the importance of early diagnosis, appropriate antibiotic therapy, and preventive measures.
Early diagnosis is crucial in managing enteric fever. Rapid diagnostic tests (RDTs) are gaining acceptance due to their ease of use and quick turnaround. However, their sensitivity and specificity vary. Blood culture remains the gold standard for diagnosis, although it may not always be feasible in resource-limited settings.
Antibiotic resistance is a growing concern in the treatment of enteric fever. Empirical therapy should ideally be guided by local antimicrobial susceptibility patterns. Fluoroquinolones, third-generation cephalosporins, and azithromycin are commonly used. Duration of therapy typically ranges from 7 to 14 days, depending on the patient's clinical response.
Prevention of enteric fever largely depends on improving sanitation and access to clean water. Vaccination also plays a crucial role. Both Vi polysaccharide and Ty21a vaccines are recommended for high-risk populations and travelers to endemic areas. However, their protective efficacy is not 100%, underscoring the need for complementary preventive measures.
Managing enteric fever effectively requires a multi-faceted approach. Early diagnosis, appropriate antibiotic therapy, and preventive measures are all integral components. As healthcare professionals, it is our responsibility to stay updated with the latest diagnostic tools, understand local antibiotic resistance patterns, and advocate for improved sanitation and vaccination programs. This comprehensive strategy will help us reduce the burden of this preventable disease.
1.
Mosunetuzumab in Follicular Lymphoma: Durable Responses and Manageable Safety
2.
As EGFR internalization is decreased, BUB1 controls EGFR signaling.
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
Low Income, Education Tied to Depression in Older Adults
5.
In Higher-Risk MDS, CMML, All-Oral Therapy Has Promise.
1.
Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care
2.
Next-Gen CAR Cell Therapies in Oncology: Frontiers in Solid Tumors & Hematologic Malignancies
3.
Next-Generation Sequencing in Oncology: Unlocking the Future of Precision Medicine
4.
Unlocking the Key to Treating Lymphoma: New Innovations in Cancer Research
5.
Personalizing Cancer Care: Microbiome Advances, Challenges, and Future Directions
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
2.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part IV
4.
Managing CNS diseases at the point of diagnosis in ALK + NSCLC
5.
Navigating the Complexities of Ph Negative ALL - Part XV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation